The Safety and Efficacy of Apixaban (Eliquis) in 5017 Post-bariatric Patients with 95.3% Follow-up: a Multicenter Study
Amit Surve, James E. Potts, Daniel Cottam, Mitchell Roslin, Walter Medlin, Miro Uchal, Christina Richards, Legrand Belnap
Topics & Concepts
MedicineApixabanMulticenter studyGeneral surgerySurgeryInternal medicineRandomized controlled trialAtrial fibrillationRivaroxabanWarfarinBariatric Surgery and OutcomesAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases